España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Coherus BioSciences
CHRS
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$1.39
0
0.00%
Last update: 12:08 PM
15 minutes delayed
Get Report
Watch
Coherus BioSciences (CHRS) sold assets to Hong Kong King-Friend Industrial Co. Ltd. on Wednesday, June 26, 2024 for $40.0M paid in cash
Coherus BioSciences (CHRS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Coherus BioSciences (NASDAQ:CHRS) Stock
Coherus BioSciences Stock (NASDAQ: CHRS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 01, 2024
Baird Maintains Outperform on Coherus BioScie...
Benzinga Newsdesk
Thursday, June 27, 2024
Coherus BioSciences To Divest YUSIMRY In $40M...
Benzinga Newsdesk
Friday, May 24, 2024
HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk
Monday, May 13, 2024
Truist Securities Maintains Buy on Coherus Bi...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Maintains Buy on Coherus ...
Benzinga Newsdesk
Coherus BioSciences shares are trading lower ...
Benzinga Newsdesk
Thursday, May 09, 2024
Coherus BioSciences Q1 2024 Adj EPS $(0.32) M...
Benzinga Newsdesk
Coherus Announces Full Repayment of Pharmakon...
Benzinga Newsdesk
Wednesday, May 08, 2024
Coherus To Collaborate With Cancer Research I...
Benzinga Newsdesk
Monday, April 08, 2024
Coherus Presents Preclinical Data For CHS-100...
Benzinga Newsdesk
Wednesday, March 20, 2024
HC Wainwright & Co. Maintains Buy on Coherus ...
Benzinga Newsdesk
Thursday, March 14, 2024
HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk
Wednesday, March 13, 2024
Coherus BioSciences shares are trading lower ...
Benzinga Newsdesk
Coherus BioSciences Sees FY24 R&D And SG&A Ex...
Benzinga Newsdesk
Recap: Coherus BioSciences Q4 Earnings
Benzinga Insights
Coherus BioSciences Q4 2023 Adj EPS $(0.62) M...
Benzinga Newsdesk
Earnings Scheduled For March 13, 2024
Benzinga Insights
Tuesday, March 12, 2024
Earnings Preview For Coherus BioSciences
Benzinga Insights
Wednesday, February 21, 2024
Coherus Launches UDENYCA ONBODY For Pegfilgra...
Benzinga Newsdesk
Tuesday, January 23, 2024
Baird Maintains Outperform on Coherus BioScie...
Benzinga Newsdesk
Truist Securities Maintains Buy on Coherus Bi...
Benzinga Newsdesk
Truist Securities Maintains Buy on Coherus Bi...
Benzinga Newsdesk
Monday, January 22, 2024
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?
Vandana Singh
Market-Moving News for January 22nd
Benzinga Newsdesk
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Coherus BioSciences shares are trading higher...
Benzinga Newsdesk
CORRECTION: Coherus To Divest Ophthalmology F...
Benzinga Newsdesk
Coherus Earlier Announced Agreement To Divest Ophthalmology Franchise Cimerli To Novarts' Sandoz Unit For $170M Upfront All Cash Deal
Charles Gross
Coherus To Divest Ophthalmology Franchise To ...
Benzinga Newsdesk
Friday, January 19, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, January 18, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Coherus Presents Phase 2 Clinical Data On Cas...
Benzinga Newsdesk
Wednesday, January 10, 2024
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
Avi Kapoor
Coherus Biosciences Has Announced The Termination Of Its Tigit Program Collaboration With Shanghai Junshi Biosciences, With Plans To Wind Down Their Work In The Coming Months
Charles Gross
Thursday, January 04, 2024
INOVIO Announces Clinical Collaboration And S...
Benzinga Newsdesk
Tuesday, January 02, 2024
Coherus BioSciences shares are trading higher...
Benzinga Newsdesk
Coherus Announces U.S. Launch Of LOQTORZI; Of...
Benzinga Newsdesk
Friday, December 29, 2023
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Chris Katje
FLJ Group, Bit Digital And Other Big Stocks Moving Higher In Friday's Pre-Market Session
Avi Kapoor
Wednesday, December 27, 2023
Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher
Avi Kapoor
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December
Avi Kapoor
Why Coherus BioSciences Stock Is Climbing Today
Erica Kollmann
US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY
Avi Kapoor
Coherus BioSciences shares are trading higher...
Benzinga Newsdesk
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
S&P 500, Nasdaq Set For Wobbly Open As Santa Claus Rally Fades: Analyst Sees Final Trading Sessions As 'Last Great Buying Opportunity'
Shanthi Rexaline
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch